Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinsons DiseaseReportar como inadecuado




Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinsons Disease - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Parkinson-s DiseaseVolume 2012 2012, Article ID 131058, 8 pages

Review Article

Unidad de Neuropsicofarmacología Traslacional, Complejo Hospitalario Universitario de Albacete, C-Hermanos Falcó 37, 02006 Albacete, Spain

Grupo de Neurofarmacología, Departamento Ciencias Médicas, Facultad de Medicina de Albacete, Universidad Castilla-La Mancha, IDINE, 02006 Albacete, Spain

Received 27 June 2012; Accepted 18 July 2012

Academic Editor: José Manuel Fuentes Rodríguez

Copyright © 2012 Maria F. Galindo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

We discuss the participation of mitochondrial dynamics and autophagy in the 6-hydroxidopamine-induced Parkinson’s disease model. The regulation of dynamic mitochondrial processes such as fusion, fission, and mitophagy has been shown to be an important mechanism controlling cellular fate. An imbalance in mitochondrial dynamics may contribute to both familial and sporadic neurodegenerative diseases including Parkinson’s disease. With special attention we address the role of second messengers as the role of reactive oxygen species and the mitochondria as the headquarters of cell death. The role of molecular signaling pathways, for instance, the participation of Dynamin-related protein 1Drp1, will also be addressed. Furthermore evidence demonstrates the therapeutic potential of small-molecule inhibitors of mitochondrial division in Parkinson’s disease. For instance, pharmacological inhibition of Drp1, through treatment with the mitochondrial division inhibitor-1, results in the abrogation of mitochondrial fission and in a decrease of the number of autophagic cells. Deciphering the signaling cascades that underlie mitophagy triggered by 6-OHDA, as well as the mechanisms that determine the selectivity of this response, will help to better understand this process and may have impact on human treatment strategies of Parkinson’s disease.





Autor: Maria F. Galindo, Maria E. Solesio, Sandra Atienzar-Aroca, Maria J. Zamora, and Joaquín Jordán Bueso

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados